Blog

Careers

Advertise

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News

HSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids

March 9, 2018 by admin 2018 Press Releases 0 comments
Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released the following statement encouraging the Drug Enforcement Administration (DEA) to take critical steps to ease current shortages of injectable opioids:
“Hospitals and other healthcare providers are currently experiencing critical shortages of a number of injectable opioid medications – including morphine, hydromorphone, and fentanyl – that are an essential element of treatment for post – surgical and medical pain management. Without the necessary opioids available, many medical procedures would have to be postponed or cancelled, jeopardizing the wellbeing of patients across the country. Controlling narcotics use – particularly outpatient prescription opioid abuse – remains a public health priority that HSCA supports.”
Read the full press release…
Next

Related Posts

HSCA Releases Second Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
August 21, 2018

Washington, DC (August 21, 2018) – The Healthcare Supply Chain Association...

Learn more
HSCA Joins Leading Healthcare Organizations in Supporting the CREATES Act (S.974)
June 7, 2018

We, the undersigned, commend you for your leadership and commitment to reducing...

Learn more
HSCA Comments on FDA Bulk Substance Guidance
May 25, 2018

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
HSCA Comments on DEA Proposed Rule on Opioid Production Limits
May 4, 2018

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Statement on President Biden’s Executive Order on the Healthcare Supply Chain
    January 22, 2021
  • HSCA Submits Comments to FDA on Using Unique Device Identifiers in Medical Device Safety Communications to Support Accuracy, Quality, and Patient Safety
    January 18, 2021